Australia's largest stock trading and investment forum Australia's #1 stock forum

PER

Click for more information

2.94%

7.0¢ percheron therapeutics limited

Not to mention getting a cell therapy through the fda is very...

First 803 Last

Share
Profile

Follow
sken

42 Posts.

3

17/10/21

18:52

Post #: 56861486
Share

Originally posted by dalts66: ↑

I think if they do go with Capricor it would also be a very good thing for ANP.

Two drugs with questional abilities to treat DMD combined, could help open a larger market share for ANP. This is if previous results can be replicated for the ANP drug.

So much to look forward to. A maccas outing. Taking itsas Lambo for a blat. Watching Davo and Rochem see if their Rovers can really climb walls. All while mephistophles stops the boys from fighting over the maccas apple pie.

Bring it on.

Expand

Not to mention getting a cell therapy through the fda is very challenging (and particularly for small companies). Just ask any mesoblast holder...

ANP Price at posting: 29.0¢ Sentiment: Buy Disclosure: Held
5 Upvote

0 Great analysis

Reply

There are more pages in this discussion • 294 more messages in this thread...

First 803 Last

Add PER (ASX) to my watchlist

(20min delay)
Last 7.0¢		Change 0.002(2.94%)		Mkt cap ! $61.30M

Open	High	Low	Value	Volume
7.0¢	7.0¢	7.0¢	$6.997K	99.95K

Buyers (Bids)

No.	Vol.	Price($)
1	44	7.0¢

Sellers (Offers)

Price($)	Vol.	No.
7.2¢	25000	1

View Market Depth

No.	Vol.	Price($)
1	44	0.070
1	14845	0.068
2	306250	0.067
1	15060	0.066
3	516040	0.065

Price($)	Vol.	No.
0.072	25000	1
0.074	133121	1
0.075	100000	1
0.076	143169	1
0.077	160000	1

Last trade - 10.07am 29/04/2024 (20 minute delay)

PER (ASX) Chart